This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Forbes, M. Articles by Peets, E. A. Search for Related Content PubMed PubMed Citation Articles by Forbes, M. Articles by Peets, E. A.

 Previous Article  |  Next Article 

J Bacteriol. 1962 November; 84(5): 1099-1103
Copyright © 1962, The Williams & Wilkins Company. All Rights Reserved.

MODE OF ACTION OF ETHAMBUTOL

Experimental Therapeutics Research, Lederle Laboratories Division, American Cyanamid Company, Pearl River, New York

ABSTRACT

FORBES, M. (Lederle Laboratories Division, Pearl River, N.Y.), N. A. KUCK, AND E. A. PEETS. Mode of action of ethambutol. J. Bacteriol. 84:1099–1103. 1962.—Ethambutol [2,2'-(ethylenediimino) di-1-butanol] arrested multiplication of Mycobacterium smegmatis cells and eventually effected their death. The inhibitory effect of the drug on multiplication did not become apparent until several hours after its addition to the culture. The drug had no effect on the survival of nonproliferating cells. It had little or no effect on the metabolism of nonproliferating cells, but cells from cultures whose growth had been inhibited by ethambutol showed evidence of impaired metabolism. C¹⁴-labeled ethambutol was taken up rapidly by both proliferating and nonproliferating cells. The observations are consistent with the hypothesis that ethambutol exerts its antibacterial effect by interfering with the synthesis of a metabolite(s) needed for multiplication. Depletion of the metabolite(s) results in arrest of multiplication, impairment of metabolism, and loss of viability. Resistance to ethambutol cannot be explained by the failure of the cells to take up the drug, since the drug was equally bound by resistant and sensitive cells.

This article has been cited by other articles:

• Shi, L., Zhou, R., Liu, Z., Lowary, T. L., Seeberger, P. H., Stocker, B. L., Crick, D. C., Khoo, K.-H., Chatterjee, D. (2008). Transfer of the First Arabinofuranose Residue to Galactan Is Essential for Mycobacterium smegmatis Viability. J. Bacteriol. 190: 5248-5255 [Abstract] [Full Text]  
• Shi, R., Zhang, J., Otomo, K., Zhang, G., Sugawara, I. (2007). Lack of Correlation between embB Mutation and Ethambutol MIC in Mycobacterium tuberculosis Clinical Isolates from China. Antimicrob. Agents Chemother. 51: 4515-4517 [Abstract] [Full Text]  
• Ramaswamy, S. V., Amin, A. G., Göksel, S., Stager, C. E., Dou, S.-J., El Sahly, H., Moghazeh, S. L., Kreiswirth, B. N., Musser, J. M. (2000). Molecular Genetic Analysis of Nucleotide Polymorphisms Associated with Ethambutol Resistance in Human Isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44: 326-336 [Abstract] [Full Text]  
• Khoo, K.-H., Douglas, E., Azadi, P., Inamine, J. M., Besra, G. S., Brennan, P. J., Chatterjee, D. (1996). Truncated Structural Variants of Lipoarabinomannan in Ethambutol Drug-resistant Strains of Mycobacterium smegmatis. INHIBITION OF ARABINAN BIOSYNTHESIS BY ETHAMBUTOL. J. Biol. Chem. 271: 28682-28690 [Abstract] [Full Text]  
• McKenzie, M. S., Burckart, G. J., Ch'ien, L. T. (1979). Therapy Review : Drug Treatment of Tuberculous Meningitis in Childhood: A Survey of Current Practices. CLIN PEDIATR 18: 75-84